2026 Q2 Portfolio Activity
In 2026 Q2, Kalehua Capital Management LLC maintained a portfolio of 30 distinct positions. The most significant new addition was Karyopharm Therapeutics Inc, now representing 4.80% of the total fund value. They heavily accumulated shares in Veradermics Inc, increasing the position by 41.6%. Conversely, Kalehua Capital Management LLC completely exited their position in Alpha Architect 1-3 Month Box .
Position History
hover any row below to update
Loading…
Total Positions
30
Quarter
2026 Q2
Top Holding
N/A (12.8%)
Top 10 Concentration
73.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-30 of 30
Kalehua Capital Management LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
Veradermics Inc
|
|
Unknown | 12.84% | 5.48% |
#1
5
Prev: #6
|
8.5 |
—
|
42,816 | 41.6% |
P
S
|
145,695 | $17,911,743 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
XFOR
X4 Pharmaceutic...
|
Healthcare | 12.46% | 12.96% |
#2
1
Prev: #1
|
6.5 |
—
|
no change | no change |
P
S
|
3,722,840 | $17,385,663 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
Compass Pathway...
|
Healthcare | 8.31% | 3.82% |
#3
8
Prev: #11
|
5.3 |
—
|
no change | no change |
P
S
|
819,692 | $11,598,642 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SRZN
Surrozen Inc
|
Healthcare | 7.16% | 9.46% |
#4
1
Prev: #3
|
4.4 |
—
|
no change | no change |
P
S
|
385,178 | $9,995,369 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACRS
Aclaris Therape...
|
Healthcare | 6.95% | 4.23% |
#5
4
Prev: #9
|
5.8 |
—
|
494,809 | 37.0% |
P
S
|
1,832,365 | $9,693,211 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SION
Sionna Therapeu...
|
Healthcare | 6.21% | 6.66% |
#6
1
Prev: #5
|
3.5 |
—
|
no change | no change |
P
S
|
197,072 | $8,669,197 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IKT
Inhibikase Ther...
|
Healthcare | 5.56% | 3.79% |
#7
5
Prev: #12
|
4.7 |
—
|
1,149,282 | 43.0% |
P
S
|
3,821,890 | $7,758,437 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
Pharvaris NV
|
Healthcare | 4.93% | 4.73% |
#8
Prev: #8
|
3.0 |
—
|
no change | no change |
P
S
|
198,772 | $6,873,536 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KPTI
Karyopharm Ther...
|
Healthcare | 4.80% | — |
#9
Prev: #—
|
5.4 |
—
|
685,644 | — |
NEW
|
685,644 | $6,698,742 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SEPN
Septerna Inc
|
Healthcare | 4.67% | 3.94% |
#10
Prev: #10
|
2.9 |
—
|
no change | no change |
P
S
|
194,544 | $6,515,279 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IFRX
Inflarx Nv
|
Healthcare | 4.65% | — |
#11
Prev: #—
|
5.4 |
—
|
2,897,769 | — |
NEW
|
2,897,769 | $6,491,003 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYCN
Cyclerion Thera...
|
Healthcare | 4.01% | — |
#12
Prev: #—
|
5.1 |
—
|
1,651,350 | — |
NEW
|
1,651,350 | $5,598,077 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
Uniqure Nv
|
Healthcare | 2.62% | 2.92% |
#13
2
Prev: #15
|
1.0 |
—
|
-132,295 | -62.5% |
P
S
|
79,407 | $3,657,486 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LONA
LeonaBio Inc
|
Healthcare | 2.59% | 3.41% |
#14
1
Prev: #13
|
2.0 |
—
|
no change | no change |
P
S
|
393,701 | $3,618,112 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLTO
Damora Therapeu...
|
Healthcare | 2.59% | 3.04% |
#15
1
Prev: #14
|
2.0 |
—
|
no change | no change |
P
S
|
139,000 | $3,615,390 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLTX
MoonLake Immuno...
|
Healthcare | 2.45% | 2.76% |
#16
Prev: #16
|
2.0 |
—
|
no change | no change |
P
S
|
175,734 | $3,421,541 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TYRA
Tyra Bioscience...
|
Healthcare | 1.70% | 2.40% |
#17
Prev: #17
|
1.7 |
—
|
no change | no change |
P
S
|
74,465 | $2,378,412 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVCT
Nuvectis Pharma...
|
Healthcare | 1.32% | — |
#18
Prev: #—
|
4.0 |
—
|
100,000 | — |
NEW
|
100,000 | $1,839,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GOSS
Gossamer Bio In...
|
Healthcare | 1.32% | 2.07% |
#19
1
Prev: #18
|
3.0 |
—
|
3,677,523 | 49.2% |
P
S
|
11,149,363 | $1,835,185 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MIST
Milestone Pharm...
|
Healthcare | 1.22% | — |
#20
Prev: #—
|
4.0 |
—
|
1,269,237 | — |
NEW
|
1,269,237 | $1,700,778 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ATYR
Atyr Pharma Inc
|
Healthcare | 0.76% | — |
#21
Prev: #—
|
3.8 |
—
|
1,788,167 | — |
NEW
|
1,788,167 | $1,067,178 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TIL
Instil Bio Inc
|
Healthcare | 0.55% | 0.97% |
#22
1
Prev: #21
|
0.2 |
—
|
-40,249 | -28.8% |
P
S
|
99,600 | $765,924 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TCRX
Tscan Therapeut...
|
Healthcare | 0.32% | — |
#23
Prev: #—
|
3.6 |
—
|
454,876 | — |
NEW
|
454,876 | $445,824 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DMAC
DiaMedica Thera...
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-62,488 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KLRS
Kalaris Therape...
|
Healthcare | 0.00% | 0.66% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-135,585 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PEPG
PepGen Inc
|
Healthcare | 0.00% | 1.09% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-729,961 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNYA
Tenaya Therapeu...
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-2,000,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
Oruka Therapeut...
|
Healthcare | 0.00% | 4.90% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-118,524 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
Relay Therapeut...
|
Healthcare | 0.00% | 7.56% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-901,457 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BOXX
Alpha Architect...
|
ETF | 0.00% | 11.61% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-118,422 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-30 of 30 holdings